P2.13-16 Preference of Adjuvant Treatments for EGFR-Mutant Resected NSCLC Patients: Results of a National-Wide Survey in China

Autor: Guo, M., Huang, W., Zhao, Y., Liang, W., He, J.
Zdroj: In Journal of Thoracic Oncology October 2018 13(10) Supplement:S804-S804
Databáze: ScienceDirect